Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Myers Scott Dunseth Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 5,797 shares @ $0
07/06/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 35,634 shares @ $0
05/31/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 5,357 shares @ $0
Granted 22,500 options to buy @ $11.2, valued at $252k
04/04/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 34,925 shares @ $0
03/13/2023 4 Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Bought 5,500 shares @ $29.1499, valued at $160.3k
02/07/2023 4 Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 250,000 shares @ $0
Granted 1,000,000 options to buy @ $35.8, valued at $35.8M
02/07/2023 3 Myers Scott Dunseth (CEO) has filed a Form 3 on Viridian Therapeutics, Inc.\DE
01/04/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns: Granted 87,500 options to buy @ $1.13, valued at $98.9k
06/24/2022 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 20,334 options to buy @ $2.01, valued at $40.9k
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns: Granted 40,000 options to buy @ $3.31, valued at $132.4k
11/19/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 67,000 options to buy @ $9.51, valued at $637.2k
10/26/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $6.31, valued at $64.2k
10/21/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 10,714 restricted stock units @ $0
Granted 45,000 options to buy @ $17.55, valued at $789.8k
10/21/2021 3 Myers Scott Dunseth (Director) has filed a Form 3 on DYNAVAX TECHNOLOGIES CORP
05/14/2021 4/A Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $0
05/07/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $22.5, valued at $228.8k
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2020 4 Myers Scott Dunseth (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.
Txns: Disposed/sold 1,000,000 options to buy @ $0
06/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2020 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $20.59, valued at $209.3k
04/30/2020 4 Myers Scott Dunseth (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.
Txns: Granted 1,000,000 options to buy @ $8.2, valued at $8.2M
04/30/2020 3 Myers Scott Dunseth (President & CEO) has filed a Form 3 on AMAG PHARMACEUTICALS, INC.
12/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/20/2019 4 Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns: Granted 41,436 shares @ $1.81, valued at $75k
06/18/2019 4 Myers Scott Dunseth (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns: Granted 20,000 options to buy @ $2.1, valued at $42k
06/18/2019 3 Myers Scott Dunseth (Director) has filed a Form 3 on SELECTA BIOSCIENCES INC
06/05/2019 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $11.84, valued at $120.4k
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
03/13/2018 4 Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Unknown transaction of 56,787 shares @ $0
Disposed/sold 474,810 options to buy @ $7.08, valued at $3.4M
Disposed/sold 190,000 options to buy @ $4.64, valued at $881.6k
Disposed/sold 60,000 options to buy @ $3.99, valued at $239.4k
Disposed/sold 42,000 restricted stock units @ $0
Disposed/sold 15,500 restricted stock units @ $0
Disposed/sold 6,300 restricted stock units @ $0
Disposed/sold 250,000 restricted stock units @ $0
02/02/2018 4 Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $0
01/16/2018 4 Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Paid exercise price by delivering 3,429 shares @ $3.92, valued at $13.4k
Exercised 10,500 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy